Mammary-derived growth inhibitor (MDGI) interacts with integrin α-subunits and suppresses integrin activity and invasion. 2010

J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
Medical Biotechnology, VTT Technical Research Centre of Finland, Turku, Finland.

The majority of mortality associated with cancer is due to formation of metastases from the primary tumor. Adhesion mediated by different integrin heterodimers has an important role during cell migration and invasion. Protein interactions with the β1-integrin cytoplasmic tail are known to influence integrin affinity for extracellular ligands, but regulating binding partners for the α-subunit cytoplasmic tails have remained elusive. In this study, we show that mammary-derived growth inhibitor (MDGI) (also known as FABP-3 or H-FABP) binds directly to the cytoplasmic tail of integrin α-subunits and its expression inhibits integrin activity. In breast cancer cell lines, MDGI expression correlates with suppression of the active conformation of integrins. This results in reduced integrin adhesion to type I collagen and fibronectin and inhibition of cell migration and invasion. In tissue microarray of 1331 breast cancer patients, patients with MDGI-positive tumors had more favorable 10-year distant disease-free survival compared with patients with MDGI-negative tumors. Our data indicate that MDGI is a novel interacting partner for integrin α-subunits, and its expression modulates integrin activity and suppresses cell invasion in breast cancer patients. Retained MDGI expression is associated with favorable prognosis.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D005109 Extracellular Matrix A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere. Matrix, Extracellular,Extracellular Matrices,Matrices, Extracellular
D005260 Female Females
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074026 Fatty Acid Binding Protein 3 A small cytosolic fatty-acid binding protein that forms a lipid-binding beta-barrel structure and is expressed by CARDIOMYOCYTES and at lower levels in brain tissue. It is released into plasma immediately following cardiac injury and may therefore serve as a useful biomarker for the early detection of MYOCARDIAL INFARCTION. H-FABP,Heart Fatty Acid Binding Protein,Heart-Specific Fatty Acid Binding Protein,Muscle Fatty Acid-Binding Protein,Heart Specific Fatty Acid Binding Protein,Muscle Fatty Acid Binding Protein

Related Publications

J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
January 1992, Cancer treatment and research,
J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
May 1989, Biochemical and biophysical research communications,
J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
January 1989, Biomedica biochimica acta,
J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
November 1987, Biochemical and biophysical research communications,
J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
November 1992, Biochemical and biophysical research communications,
J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
January 1990, Acta histochemica. Supplementband,
J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
January 1995, In vitro cellular & developmental biology. Animal,
J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
February 1989, Journal of cellular physiology,
J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
January 1990, Virchows Archiv. B, Cell pathology including molecular pathology,
J Nevo, and A Mai, and S Tuomi, and T Pellinen, and O T Pentikäinen, and P Heikkilä, and J Lundin, and H Joensuu, and P Bono, and J Ivaska
November 1996, Cancer research,
Copied contents to your clipboard!